AzTrials
AzTrials

ThyroidectomyORCNCT01171079

Use of an Oxidized Regenerated Cellulose After Thyroid Surgery: A Prospective, Randomized Study

A study testing application of oxidized regenerated cellulose in people with Thyroidectomy, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effects and safety of oxidized, regenerated cellulose as an absorbable adhesion barrier after thyroidectomy. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Thyroidectomy
What is being tested?
application of oxidized regenerated cellulose
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
Not given
Where
1 siteSouth Korea
Study dates
Start not givento not given
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Adult, Older adult

Who may be able to join

  • operable thyroid neoplasm

Who cannot join

  • a history of previous neck surgeries or uncontrolled medical diseases such as hyperthyroidism, diabetes, and hypertension
  • administration of non-steroidal anti-inflammatory drugs (NSAIDs) or anti-platelet agents within 1 week before surgery

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University College of Medicine

    Seoul, 110-744

Other trials in South Korea

About this study

The purpose of this study is to evaluate the effects and safety of oxidized, regenerated cellulose as an absorbable adhesion barrier after thyroidectomy.

Conditions
Thyroidectomy
Being tested
application of oxidized regenerated cellulose
Keywords
postoperative adhesion after thyroidectomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • application of oxidized regenerated celluloseDevice

Study groups in NCT01171079
Study groupRoleWhat they receive
InterceedExperimentalNot described
Receives: Device: application of oxidized regenerated cellulose

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
IDs, dates and publications
ClinicalTrials.gov ID
NCT01171079
Sponsor's protocol ID
ORC-100
Acronym
ORC
Status last verified
Jul 2010
First submitted
26 Jul 2010
Last updated
28 Jul 2010
Results posted
No

Publications

  • Yigit O, Uslu Coskun B, Coskun H, Yilmaz B, Alkan S, Cinar U, Dadas B. Efficacy of anti-adhesive barriers in secondary thyroidectomy: an experimental study. Laryngoscope. 2004 Sep;114(9):1668-73. doi: 10.1097/00005537-200409000-00031.

    PubMed 15475802
  • Yilmaz O, Genc A, Taneli F, Demireli P, Deliaga H, Taneli C. Assessment of the efficacy of absorbable adhesion barriers on dissection in esophagus operations. Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):409-14. doi: 10.1016/j.ijporl.2006.11.010. Epub 2006 Dec 11.

    PubMed 17161874

Questions about this trial

What is this clinical trial studying?

A study testing application of oxidized regenerated cellulose in people with Thyroidectomy, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01171079, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in